上海医药2024,Vol.45Issue(5) :53-57.

103例中成药不良反应的回顾分析

A retrospective analysis of 103 cases of adverse reactions of proprietary Chinese medicines

王飞 周颀 季敏
上海医药2024,Vol.45Issue(5) :53-57.

103例中成药不良反应的回顾分析

A retrospective analysis of 103 cases of adverse reactions of proprietary Chinese medicines

王飞 1周颀 1季敏2
扫码查看

作者信息

  • 1. 上海市杨浦区中医医院药剂科 上海 200090
  • 2. 上海市杨浦区精神卫生中心院办 上海 200090
  • 折叠

摘要

本文从患者性别和年龄、不良反应类型及给药途径、涉及的药物品种、主要临床表现及累及器官/系统,以及中成药不良反应与用药适宜性等多方面,对103 例中成药不良反应病例进行回顾性分析.引发中成药不良反应的因素较多,加强中成药使用过程中的用药安全监测需要医者、医疗管理者、药师与患者四方联动共同推进,才能有效减少中成药不良反应的发生.

Abstract

In this paper,103 cases of adverse reactions of proprietary Chinese medicines were retrospectively analyzed in terms of gender and age of the patients,types of adverse reactions and routes of administration,types of drugs involved,major clinical manifestations and organs/systems involved,as well as adverse reactions of proprietary Chinese medicines and appropriateness of medication.There are many factors contributing to the adverse reactions of proprietary Chinese medicines,and strengthening medication safety monitoring during their use requires the joint promotion of medical practitioners,healthcare administrators,pharmacists and patients so as to effectively reduce the occurrence of adverse reactions of proprietary Chinese medicines.

关键词

中成药/不良反应/用药安全

Key words

proprietary Chinese medicine/adverse reaction/medication safety

引用本文复制引用

出版年

2024
上海医药
上海医药行业协会

上海医药

影响因子:0.781
ISSN:1006-1533
参考文献量4
段落导航相关论文